Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Dec;66(6):1159–1163. doi: 10.1038/bjc.1992.427

Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia.

H Bentley 1, F C Hamdy 1, K A Hart 1, J M Seid 1, J L Williams 1, D Johnstone 1, R G Russell 1
PMCID: PMC1978039  PMID: 1280991

Abstract

There are important interactions between prostatic tumours and bone. This study was designed to examine whether prostatic tissue can express bone inductive factors, in particular, the Bone Morphogenetic Proteins (BMPs). The polymerase chain reaction (PCR) has been used to screen for the expression of BMPs one to six in the prostatic tissue of patients with benign prostatic hyperplasia (BPH), non-metastatic prostatic adenocarcinoma and metastatic prostatic adenocarcinoma. BMPs were expressed in both benign and malignant prostate tissue and in the prostate tumour cell lines, PC3 and DU145. BMPs were also expressed in ocular melanoma tissue, a tissue which rarely metastasizes to bone. BMP-6 expression was detected in the prostate tissue of over 50% of patients with clinically defined metastatic prostate adenocarcinoma, but was not detected in non-metastatic or benign prostate samples or in ocular melanoma tissue. These findings suggest that the BMPs may play a role in the osteoinductive activity of prostate metastases and that the pattern of expression of BMPs may be important in the pathogenesis of osteoblastic metastases associated with prostate adenocarcinoma.

Full text

PDF
1159

Images in this article

1161Figure 1
on p.1161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brenner C. A., Tam A. W., Nelson P. A., Engleman E. G., Suzuki N., Fry K. E., Larrick J. W. Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques. 1989 Nov-Dec;7(10):1096–1103. [PubMed] [Google Scholar]
  2. Celeste A. J., Iannazzi J. A., Taylor R. C., Hewick R. M., Rosen V., Wang E. A., Wozney J. M. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9843–9847. doi: 10.1073/pnas.87.24.9843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Charhon S. A., Chapuy M. C., Delvin E. E., Valentin-Opran A., Edouard C. M., Meunier P. J. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia. Cancer. 1983 Mar 1;51(5):918–924. doi: 10.1002/1097-0142(19830301)51:5<918::aid-cncr2820510526>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  5. Hammonds R. G., Jr, Schwall R., Dudley A., Berkemeier L., Lai C., Lee J., Cunningham N., Reddi A. H., Wood W. I., Mason A. J. Bone-inducing activity of mature BMP-2b produced from a hybrid BMP-2a/2b precursor. Mol Endocrinol. 1991 Jan;5(1):149–155. doi: 10.1210/mend-5-1-149. [DOI] [PubMed] [Google Scholar]
  6. Jacobs S. C., Pikna D., Lawson R. K. Prostatic osteoblastic factor. Invest Urol. 1979 Nov;17(3):195–198. [PubMed] [Google Scholar]
  7. Kaighn M. E., Narayan K. S., Ohnuki Y., Lechner J. F., Jones L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 1979 Jul;17(1):16–23. [PubMed] [Google Scholar]
  8. Koutsilieris M., Rabbani S. A., Bennett H. P., Goltzman D. Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype. J Clin Invest. 1987 Oct;80(4):941–946. doi: 10.1172/JCI113186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Luyten F. P., Cunningham N. S., Ma S., Muthukumaran N., Hammonds R. G., Nevins W. B., Woods W. I., Reddi A. H. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem. 1989 Aug 15;264(23):13377–13380. [PubMed] [Google Scholar]
  10. Lyons K. M., Jones C. M., Hogan B. L. The DVR gene family in embryonic development. Trends Genet. 1991 Nov-Dec;7(11-12):408–412. doi: 10.1016/0168-9525(91)90265-r. [DOI] [PubMed] [Google Scholar]
  11. Lyons K. M., Pelton R. W., Hogan B. L. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development. 1990 Aug;109(4):833–844. doi: 10.1242/dev.109.4.833. [DOI] [PubMed] [Google Scholar]
  12. Lyons K. M., Pelton R. W., Hogan B. L. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development. Genes Dev. 1989 Nov;3(11):1657–1668. doi: 10.1101/gad.3.11.1657. [DOI] [PubMed] [Google Scholar]
  13. Maehama S., Li D., Nanri H., Leykam J. F., Deuel T. F. Purification and partial characterization of prostate-derived growth factor. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8162–8166. doi: 10.1073/pnas.83.21.8162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mori H., Maki M., Oishi K., Jaye M., Igarashi K., Yoshida O., Hatanaka M. Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia. Prostate. 1990;16(1):71–80. doi: 10.1002/pros.2990160108. [DOI] [PubMed] [Google Scholar]
  15. Mydlo J. H., Bulbul M. A., Richon V. M., Heston W. D., Fair W. R. Heparin-binding growth factor isolated from human prostatic extracts. Prostate. 1988;12(4):343–355. doi: 10.1002/pros.2990120408. [DOI] [PubMed] [Google Scholar]
  16. Paralkar V. M., Hammonds R. G., Reddi A. H. Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3397–3401. doi: 10.1073/pnas.88.8.3397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Simpson E., Harrod J., Eilon G., Jacobs J. W., Mundy G. R. Identification of a messenger ribonucleic acid fraction in human prostatic cancer cells coding for a novel osteoblast-stimulating factor. Endocrinology. 1985 Oct;117(4):1615–1620. doi: 10.1210/endo-117-4-1615. [DOI] [PubMed] [Google Scholar]
  18. Stone K. R., Mickey D. D., Wunderli H., Mickey G. H., Paulson D. F. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer. 1978 Mar 15;21(3):274–281. doi: 10.1002/ijc.2910210305. [DOI] [PubMed] [Google Scholar]
  19. Story M. T., Sasse J., Jacobs S. C., Lawson R. K. Prostatic growth factor: purification and structural relationship to basic fibroblast growth factor. Biochemistry. 1987 Jun 30;26(13):3843–3849. doi: 10.1021/bi00387a016. [DOI] [PubMed] [Google Scholar]
  20. Thompson T. C. Growth factors and oncogenes in prostate cancer. Cancer Cells. 1990 Nov;2(11):345–354. [PubMed] [Google Scholar]
  21. Urist M. R. Bone: formation by autoinduction. Science. 1965 Nov 12;150(3698):893–899. doi: 10.1126/science.150.3698.893. [DOI] [PubMed] [Google Scholar]
  22. Wang E. A., Rosen V., D'Alessandro J. S., Bauduy M., Cordes P., Harada T., Israel D. I., Hewick R. M., Kerns K. M., LaPan P. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2220–2224. doi: 10.1073/pnas.87.6.2220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Whitmore W. F., Jr Natural history and staging of prostate cancer. Urol Clin North Am. 1984 May;11(2):205–220. [PubMed] [Google Scholar]
  24. Wozney J. M. Bone morphogenetic proteins. Prog Growth Factor Res. 1989;1(4):267–280. doi: 10.1016/0955-2235(89)90015-x. [DOI] [PubMed] [Google Scholar]
  25. Wozney J. M., Rosen V., Celeste A. J., Mitsock L. M., Whitters M. J., Kriz R. W., Hewick R. M., Wang E. A. Novel regulators of bone formation: molecular clones and activities. Science. 1988 Dec 16;242(4885):1528–1534. doi: 10.1126/science.3201241. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES